History of the World Allergy Organization: Innovation in Continuity 2008–2009

Por Canonica, Giorgio Walter
Publicado em 2011

Impact of rhinitis on airway inflammation: biological and therapeutic implications

Por Passalacqua, Giovanni, Canonica, Giorgio Walter
Publicado em 2001

Local Nasal Specific Immunotherapy for Allergic Rhinitis

Por Passalacqua, Giovanni, Canonica, Giorgio Walter
Publicado em 2006

Is Sublingual Immunotherapy the Final Answer? Implications for the Allergist

Por Canonica, Giorgio Walter, Passalacqua, Giovanni
Publicado em 2008

AIT (allergen immunotherapy): a model for the “precision medicine”

Por Passalacqua, Giovanni, Canonica, Giorgio Walter
Publicado no Clin Mol Allergy (2015)

409 Oral Allergy Syndrome and United Airways Disease: Is There a Functional Connection?

Por Lombardi, Carlo, Passalacqua, Giovanni, Canonica, Giorgio Walter
Publicado em 2012

Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper

Por Passalacqua, Giovanni, Compalati, Enrico, Canonica, Giorgio Walter
Publicado em 2010

European medicines agency guideline for biological medicinal products: a further step for a safe use of biosimilars

Por Agostini, Carlo, Canonica, Giorgio Walter, Maggi, Enrico
Publicado no Clin Mol Allergy (2015)

The WEB-based Asthma Control: an intriguing connection or a dangerous hazard?

Por Lombardi, Carlo, Passalacqua, Giovanni, Canonica, Giorgio Walter
Publicado no Asthma Res Pract (2015)

Asthma research and practice: a new journey begins

Por Celedon, Juan C., Passalacqua, Giovanni, Canonica, Giorgio Walter
Publicado no Asthma Res Pract (2015)

Prevalence of perennial severe allergic asthma in Italy and effectiveness of omalizumab in its management: PROXIMA – an observational, 2 phase, patient reported outcomes study

Por Canonica, Giorgio Walter, Bartezaghi, Marta, Marino, Raffaele, Rigoni, Laura
Publicado no Clin Mol Allergy (2015)

Allergen immunotherapy in asthma; what is new?

Por Passalacqua, Giovanni, Rogkakou, Anthi, Mincarini, Marcello, Canonica, Giorgio Walter
Publicado no Asthma Res Pract (2015)

Spiromax, a New Dry Powder Inhaler: Dose Consistency under Simulated Real-World Conditions

Por Canonica, Giorgio Walter, Arp, Jan, Keegstra, Johan René, Chrystyn, Henry
Publicado no J Aerosol Med Pulm Drug Deliv (2015)

May We Strengthen the Human Natural Defenses with Bacterial Lysates?

Por Villa, Elisa, Garelli, Valentina, Braido, Fulvio, Melioli, Giovanni, Canonica, Giorgio Walter
Publicado em 2010

Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey

Por Braido, Fulvio, Baiardini, Ilaria, Sumberesi, Massimo, Blasi, Francesco, Canonica, Giorgio Walter
Publicado em 2013

Bilastine: new insight into antihistamine treatment

Por Ridolo, Erminia, Montagni, Marcello, Bonzano, Laura, Incorvaia, Cristoforo, Canonica, Giorgio Walter
Publicado no Clin Mol Allergy (2015)

Switching treatments in COPD: implications for costs and treatment adherence

Por Braido, Fulvio, Lavorini, Federico, Blasi, Francesco, Baiardini, Ilaria, Canonica, Giorgio Walter
Publicado no Int J Chron Obstruct Pulmon Dis (2015)

Psychological aspects in asthma: do psychological factors affect asthma management?

Por Baiardini, Ilaria, Sicuro, Francesca, Balbi, Francesco, Canonica, Giorgio Walter, Braido, Fulvio
Publicado no Asthma Res Pract (2015)

Is allergic sensitization relevant in severe asthma? Which allergens may be culprit?

Por Lombardi, Carlo, Savi, Eleonora, Ridolo, Erminia, Passalacqua, Giovanni, Canonica, Giorgio Walter
Publicado no World Allergy Organ J (2017)

The perception of allergen-specific immunotherapy among pediatricians in the primary care setting

Por Landi, Massimo, Meglio, Paolo, Praitano, Ermanno, Lombardi, Carlo, Passalacqua, Giovanni, Canonica, Giorgio Walter
Publicado no Clin Mol Allergy (2015)